(6,6'-Dimethoxy-2,2'-biphenyldiyl)bis{bis[3,5-bis(2-methyl-2-propanyl)phenyl]phosphine}
|
811-688-4
|
192138-05-9
|
|
Notified C&L
|
View details
|
(6,6'-Dimethoxy-2,2'-biphenyldiyl)bis{bis[3,5-bis(2-methyl-2-propanyl)phenyl]phosphine}
|
811-690-5
|
167709-31-1
|
|
Notified C&L
|
View details
|
(-)-4,5-Bis[(2R,5R)-2,5-dimethylphospholanyl](1,2-dimethyl-1,2-dihydropyridazine-3,6-dione)(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate
|
811-691-0
|
908128-78-9
|
|
Notified C&L
|
View details
|
(-)-1,1'-Bis((2S,4S)-2,4-diethylphosphotano)ferrocene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate,
|
943-099-4
|
|
|
Notified C&L
|
View details
|
1,1-Bis((2R,5R)-2,5-dimethylphospholano)ferrocene(cyclooctadiene)rhodium(I) tetrafluoroborate
|
811-692-6
|
854275-87-9
|
|
Notified C&L
|
View details
|
(4S)-4-Benzyl-2-[(1S)-7'-(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-yl]-4,5-dihydro-1,3-oxazole
|
811-693-1
|
913829-88-6
|
|
Notified C&L
|
View details
|
4,4'-Bi-1,3-benzodioxole-5,5'-diylbis{bis[4-methoxy-3,5-bis(2-methyl-2-propanyl)phenyl]phosphine}
|
811-694-7
|
566940-03-2
|
|
Notified C&L
|
View details
|
Methanesulfonato(tri-t-butylphosphino)(2'-amino-1,1'-biphenyl-2-yl)palladium(II)
|
811-695-2
|
1445086-17-8
|
|
Notified C&L
|
View details
|
Chloro[2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)-1,1'-biphenyl](2'-amino-1,1'-biphenyl-2-yl)palladium(II)
|
943-100-8
|
|
|
Notified C&L
|
View details
|
Methanesulfonato(2-dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II)
|
811-696-8
|
1599466-81-5
|
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
Aquatic Chronic 3
|
Notified C&L
|
View details
|
{1-[(4R)-2-(1-Adamantyl-4,5-dihydrooxazolyl)ethyl]-3-(2,6-di-i-propylphenyl)imidazolin-2-ylidene}(1,5-cyclooctadiene)iridium(I) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
|
811-697-3
|
934621-82-6
|
|
Notified C&L
|
View details
|
{1-[(4S)-2-(1-Adamantyl-4,5-dihydrooxazolyl)ethyl]-3-(2,6-di-i-propylphenyl)imidazolin-2-ylidene}(1,5-cyclooctadiene)iridium(I) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
|
811-698-9
|
369657-32-9
|
|
Notified C&L
|
View details
|
N-[(2E,4E)-4-(Phenylimino)-2-penten-2-yl]aniline
|
811-699-4
|
19164-92-2
|
|
Notified C&L
|
View details
|
+)-{(1S,4R)-3-[4-(Diphenylphosphino)-2,5-dimethyl-3-thienyl]-4,7,7-trimethylbicyclo[2.2.1]hept-2-en-2-yl}bis(3,5-dimethylphenylphosphine
|
811-700-8
|
1272755-16-4
|
|
Notified C&L
|
View details
|
1,2,3,4,5-Cyclopentanepentayl, compd. with 1-[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]-2-[(1S)-1-(dicyclohexylphosphino)ethyl]-1,2,3,4,5-cyclopentanepentayl, iron salt (1:1:1)
|
811-701-3
|
292638-88-1
|
|
Notified C&L
|
View details
|
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-methyl-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate
|
943-101-3
|
|
|
Notified C&L
|
View details
|
(+)-2,3-Bis[(2S,5S)-2,5-dimethylphospholanyl]-1-methyl-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate
|
943-102-9
|
|
|
Notified C&L
|
View details
|
1R,1'R,2S,2'S)-(+)-2,2'-Di-t-butyl-2,3,2',3'-tetrahydro-1,1'-bi-1H-isophosphindole(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate,
|
943-103-4
|
|
|
Notified C&L
|
View details
|
Methanesulfonato{(R)-(-)-1-[(S)-2-(dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II)
|
943-105-5
|
|
|
Notified C&L
|
View details
|
2-fluoro-6-nitro-N-phenylbenzamide
|
811-702-9
|
870281-83-7
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
tert-butyl N-[(1S)-1-(5-fluoro-4-oxo-3-phenylquinazolin-2-yl)propyl]carbamate
|
811-703-4
|
870281-85-9
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4-[2-(octyloxy)benzamido]benzoic acid
|
811-705-5
|
51444-79-2
|
|
Notified C&L
|
View details
|
3-(1H-Imidazol-5-yl)pyridine
|
943-107-6
|
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
N-((R)-1-(5-Chloro-1H-benzoimidazol-2-yl)-2-methoxy-ethyl)-3-methyl-4-(3-oxo-morpholin-4-yl)-benzamide Sodium Salt
|
811-706-0
|
1622159-00-5
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
|
Notified C&L
|
View details
|
trisodium bis[3-[1-(3-chlorophenyl)-5-(hydroxykO)-3-methyl-1H-pyrazol-4-yl]diazenyl}-4-(hydroxy-kO)5-nitrobenzenesulfonato(3-)]chromate(3-)
|
943-109-7
|
|
Skin Sens. 1
Eye Irrit. 2
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
Fatty acids, C18-unsatd., dimers, polymers with bisphenol A, epichlorohydrin, glycidyl Ph ether, tall-oil fatty acids and tetraethylenepentamine
|
811-707-6
|
73891-94-8
|
Skin Sens. 1
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2
|
Notified C&L
|
View details
|
(3-Methyl-butylamino)-3-pyridinyl methyl phosphinic acid
|
943-112-3
|
|
Acute Tox. 4
Skin Corr. 1A
Eye Dam. 1
STOT SE 3
|
Notified C&L
|
View details
|
Propane, 2-chloro-1,1,1,2-tetrafluoro-
|
811-708-1
|
421-73-8
|
|
Notified C&L
|
View details
|
2,3-dichloro-1,1,1-trifluoropropane
|
811-709-7
|
338-75-0
|
STOT SE 3
STOT SE 3
Ozone 1
|
Notified C&L
|
View details
|
Fluoropolymer~
|
863-119-4
|
1793072-86-2
|
|
Notified C&L
|
View details
|
Cinnamon essential oil; coumarin free
|
943-113-9
|
|
Skin Sens. 1
Eye Irrit. 2
Muta. 2
Carc. 1B
Aquatic Chronic 3
|
Notified C&L
|
View details
|
Angelica Root essential oil
|
943-114-4
|
|
Flam. Liq. 3
Asp. Tox. 1
Skin Sens. 1
Aquatic Chronic 2
|
Notified C&L
|
View details
|
Terpenes and Terpenoids, turpentine-oil, limonene fraction, polymers with 1-methyl-4-(1-methylethenyl)cyclohexene and turpentine-oil b-pinene fraction terpenes
|
811-710-2
|
262446-00-4
|
|
Notified C&L
|
View details
|
Methanesulfonato[2,2'-bis(diphenylphosphino)-1,1'-binaphthyl](2'-amino-1,1'-biphenyl-2-yl)palladium(II)
|
943-120-7
|
|
|
Notified C&L
|
View details
|
Reaction mass of palladium and carbon
|
943-121-2
|
|
|
Notified C&L
|
View details
|
(E)-methyl non-2-enoate
|
811-711-8
|
14952-06-8
|
Aquatic Acute 1
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
4-cyclohexylbutan-2-one
|
811-712-3
|
2316-85-0
|
Acute Tox. 3
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
3-(3-carbamoyl-2-hydroxy-4-methyl-6-oxo-1-pyridyl)propanoic acid
|
811-713-9
|
78057-29-1
|
|
REACH registration C&L
|
View details
|
Indazolpyrrolopyrimdine derivative
|
|
|
|
Notified C&L
|
View details
|
Linseed oil, polymerized, reaction products with diethanolamine
|
943-123-3
|
|
|
Notified C&L
|
View details
|
1,3-Benzodioxol-4-amine
|
811-716-5
|
1668-84-4
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
Muta. 2
|
Notified C&L
|
View details
|
3-(3-cyano-6-hydroxy-4-methyl-2-oxo-1-pyridyl)propanoic acid
|
811-717-0
|
78057-27-9
|
|
REACH registration C&L
|
View details
|
Reaction mass of butan-1-ol and Tetra-n-butyl titanate, polymer with water
|
943-125-4
|
|
Flam. Liq. 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
|
Notified C&L
|
View details
|
Reaction mass of propan-2-ol and butan-1-ol and Titanium, Bu alc. iso-Pr alc. complexes
|
943-127-5
|
|
Flam. Liq. 3
Eye Irrit. 2
|
Notified C&L
|
View details
|
Reaction mass of 2-ethylhexan-1-ol and titanium tetraisopropanolate and titanium tetrakis(2-ethylhexanolate)
|
943-128-0
|
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;
medetomidine
613-321-00-1
|
811-718-6
|
86347-14-0
|
Acute Tox. 2
Acute Tox. 2
STOT SE 3
STOT SE 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
|
Harmonised C&L
|
View details
|
3-(2-((4-Carbamimidoylphenyl)carbamoyl)-4-ethenyl-5-methoxyphenyl)-6-((cyclopropylmethyl)carbamoyl)pyridine-2-carboxylic acid
|
811-719-1
|
918407-35-9
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide dihydrochloride
|
811-720-7
|
1380317-28-1
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
Repr. 2
STOT RE 2
|
Notified C&L
|
View details
|
Reaction mass of 141-78-6 and 1421259-21-3
|
943-129-6
|
|
Flam. Liq. 2
Skin Sens. 1
Eye Irrit. 2
STOT SE 3
Repr. 2
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
811-721-2
|
84784-84-9
|
|
Notified C&L
|
View details
|
|
|
|
|
|
|